BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs7903146
,
BRCA1
,
Coagulation
,
Leukemia
,
Stem cell
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
v abl
Summary
General Info
Curated Studies
Most Correlated Studies
Imatinib resistant chronic myeloid leukemia TF1 cells with BCR-ABL gene fusion
Pre-B cells double-stranded breaks (DSBs) induced not repaired
Expression data for program activation by IR-induced DNA breaks in G1 phase preB cells
MCF10F fibroadenoma cells - gene expression associated with E2-transformation and tumorigenicity
Lungs of A/J mice exposed to cigarette smoke or normal air
Explore Curated Studies Results
Literature
Most Relevant Literature
The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia.
Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report a…
Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia.
Comparison of BCR::ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic…
Beyond BCR::ABL1-The Role of Genomic Analyses in the Management of CML.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Eur…
99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis
OMEGA, Local Ablative Therapy in Oligometastatic NSCLC
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
XIENCE V: SPIRIT WOMEN
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ